(Q33659233)

English

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

psoriatic arthritis

1 reference

based on heuristic

inferred from title

oligoarticular juvenile idiopathic arthritis

1 reference

based on heuristic

inferred from title

Rubén Burgos-Vargas

2

object named as

Ruben Burgos-Vargas

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jelena Vojinovic

object named as

Jelena Vojinovic

5

0 references

Pavla Doležalová

object named as

Pavla Dolezalova

16

0 references

Nicolino Ruperto

25

object named as

Nicolino Ruperto

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Nico M Wulffraat

18

object named as

Nico Wulffraat

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Alberto Martini

24

object named as

Alberto Martini

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

object named as

Gerd Horneff

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Paediatric Rheumatology International Trials Organisation (PRINTO)

26

object named as

Paediatric Rheumatology International Trials Organisation (PRINTO)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

object named as

Ivan Foeldvari

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Tamas Constantin

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Vyacheslav G Chasnyk

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Joke Dehoorne

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Violeta Panaviene

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Gordana Susic

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Valda Stanevica

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Katarzyna Kobusinska

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Zbigniew Zuber

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Richard Mouy

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ingrida Rumba-Rozenfelde

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Luciana Breda

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Chantal Job-Deslandre

17

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Daniel Alvarez

19

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Chuanbo Zang

20

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Joseph Wajdula

21

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Deborah Woodworth

22

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Bonnie Vlahos

23

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

21 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1114-1122

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Is it time to move to active comparator trials in juvenile idiopathic arthritis?: a review of current study designs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Efficacy and safety of TNFalpha antagonist therapy in patients with juvenile spondyloarthropathies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Medical treatment of juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Epidemiology of chronic arthritis in childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

21 June 2018

Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203046

21 January 2018

Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203046

21 January 2018

American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203046

21 January 2018

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203046

21 January 2018

Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203046

21 January 2018

Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203046

21 January 2018

Prolonged efficacy of etanercept in refractory enthesitis-related arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033142

30 October 2018

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203046

21 January 2018

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of health status in children with juvenile rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary definition of improvement in juvenile arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Juvenile idiopathic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Juvenile idiopathic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ANNRHEUMDIS-2012-203046

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33659233&oldid=1834994205"